The FDA has accepted a New Drug Application (NDA) for Celcuity’s gedatolisib in hormone receptor positive (HR+), human ...
Everyday Health on MSN
The pros, cons, and considerations of taking Ozempic or other drugs for weight loss
Use of the diabetes drug Ozempic for weight loss is rising. Understand the research, how it works, who should use it, and potential side effects.
Health and Human Services Secretary Robert F. Kennedy Jr. tells USA TODAY where his personal concerns about vaccines and food ...
Gedatolisib's NDA for advanced breast cancer treatment has been accepted by the FDA, with a priority review and a PDUFA date set for July 17, 2026. The drug is intended for HR+/HER2–, PIK3CA wild-type ...
Stocktwits on MSN
CAPR stock slides after FDA requests more data for genetic disorder therapy — what does retail think?
Capricor now plans to submit the data requested by the FDA in February. ・CEO Linda Marbán said that the company is “pleased” ...
A state lawmaker wants the South Dakota Legislature to address how ivermectin and hydroxychloroquine are dispensed to ...
The firm filed data from the Phase III VIKTORIA-1 trial, which evaluated gedatolisib with fulvestrant with or without a CDK4/6 inhibitor.
Ionis is up ~25%. Explore why Olezarsen, recent approvals, and upcoming catalysts could drive more upside. Click here to read ...
Hodgman explains how he jumped at the opportunity to work with Long, who has been a friend and creative collaborator for ...
FDA approves first brain stimulation device for home depression treatment. Flow Neuroscience's FL-100 headset uses electrical ...
Pharmaceutical company Boehringer Ingelheim said on Monday the U.S. Food and Drug Administration had approved its chewable ...
On Friday, the U.S. Supreme Court granted certiorari to a petition filed by patent owner Hikma Pharmaceuticals, taking up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results